000131196 001__ 131196
000131196 005__ 20240206154529.0
000131196 0247_ $$2doi$$a10.51507/j.jams.2021.14.2.82
000131196 0248_ $$2sideral$$a126648
000131196 037__ $$aART-2021-126648
000131196 041__ $$aeng
000131196 100__ $$aMotamedzadeh O.
000131196 245__ $$aA study on the effects of dry needling in multiple sclerosis patients with spasticity: Protocol of a randomized waitlist-controlled trial
000131196 260__ $$c2021
000131196 5060_ $$aAccess copy available to the general public$$fUnrestricted
000131196 5203_ $$aBackground: Spasticity is a common symptom in multiple sclerosis (MS). Dry needling (DN) has been considered a useful method for the treatment of spasticity; however, there are no studies on the effects of DN on spasticity in patients with MS. We propose a study protocol aiming to investigate the effects of DN on spasticity in patients with MS. Methods: MS patients with plantar flexor spasticity will be recruited. Participants will be randomly assigned to the DN group, where they will be receiving a single session of DN, one minute for each head of gastrocnemius muscle, or to the waiting list control group with no intervention. Primary outcome measures are the Modified Ashworth Scale (MAS) for gastrocnemius spasticity, passive resistive torque, and podography for foot pressure distribution. The ankle active and passive range of dorsiflexion and Timed Up and Go tests are the secondary outcome measures. All outcomes will be measured at baseline, immediately after the intervention, and one week later. A mixed-model, general linear model, and two-way repeated-measures ANOVA will be used to compare the quantitative variables between groups and within groups at the measurement time points. The MAS ordinal measure of spasticity will be compared between groups using the Kruskal-Wallis test, and both the Friedman test and Wilcoxon test will be used for within-group changes. Discussion: This study will provide primary evidence on the effects of DN on gastrocnemius muscle spasticity and gait in patients with MS. © 2021 Korean Pharmacopuncture Institute. All rights reserved.
000131196 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000131196 592__ $$a0.28$$b2021
000131196 593__ $$aComplementary and Alternative Medicine$$c2021$$dQ3
000131196 593__ $$aAnesthesiology and Pain Medicine$$c2021$$dQ3
000131196 594__ $$a2.3$$b2021
000131196 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000131196 700__ $$aAnsari N.N.
000131196 700__ $$aNaghdi S.
000131196 700__ $$aAzimi A.
000131196 700__ $$aMahmoudzadeh A.
000131196 700__ $$0(orcid)0000-0002-1674-7788$$aCalvo S.$$uUniversidad de Zaragoza
000131196 700__ $$0(orcid)0000-0002-9201-0120$$aHerrero P.$$uUniversidad de Zaragoza
000131196 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000131196 773__ $$g14, 2 (2021), 82-88$$tJAMS Journal of Acupuncture and Meridian Studies$$x2005-2901
000131196 8564_ $$s456062$$uhttps://zaguan.unizar.es/record/131196/files/texto_completo.pdf$$yVersión publicada
000131196 8564_ $$s2958244$$uhttps://zaguan.unizar.es/record/131196/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000131196 909CO $$ooai:zaguan.unizar.es:131196$$particulos$$pdriver
000131196 951__ $$a2024-02-06-14:48:37
000131196 980__ $$aARTICLE